"Optum is a leading information and technology-enabled health services business dedicated to helping make the health system work better for everyone. With more than 180,000 people worldwide, Optum delivers intelligent, integrated solutions that help to modernize the health system and improve overall population health. Optum is part of UnitedHealth Group (NYSE:UNH)."

During the past decade, Optumcare Colorado Springs - Monument conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Optumcare Colorado Springs - Monument" are "Obesity" (1 trials), "Overweight" (1 trials) and "Type 2 Diabetes" (1 trials). Many other conditions were trialed in "Optumcare Colorado Springs - Monument" in a lesser frequency.

Most popular intervention types in "Optumcare Colorado Springs - Monument" are "Drug" (2 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (2 trials), "Dulaglutide" (1 trials), "LY3502970" (1 trials) and "Tirzepatide" (1 trials). Other intervention names were less common.

The vast majority of trials in "Optumcare Colorado Springs - Monument" are 2 trials for "All" genders.

Currently, there are NaN active trials in "Optumcare Colorado Springs - Monument". undefined are not yet recruiting, undefined are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 1 completed trials in Optumcare Colorado Springs - Monument, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Optumcare Colorado Springs - Monument, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 1 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".